Chronic Pain and Neuropathic Pain
Apurano Pharmaceuticals GmbH focuses on clinical research in persistent pain conditions, with particular attention to chronic back pain and pain linked to peripheral neuropathy and central neuropathy.
- Chronic back pain
- Traumatic peripheral neuropathy
- Post-operative peripheral neuropathy
- Central neuropathic pain
The sponsor also investigates pain associated with diabetic polyneuropathy, reflecting a strong therapeutic interest in difficult-to-treat nerve-related pain syndromes.
Peripheral Nervous System Disorders
Its research portfolio includes conditions arising from injury or disease affecting the peripheral nervous system, especially pain syndromes following surgery or trauma.
- Peripheral neuropathy
- Trauma-related nerve pain
- Post-surgical neuropathic pain
These studies indicate sustained interest in therapies targeting nerve dysfunction and the management of long-term sensory pain.
Diabetic Neuropathy
Apurano Pharmaceuticals GmbH is active in research addressing pain due to diabetic polyneuropathy, a major complication of diabetes mellitus involving chronic nerve damage and pain.
- Diabetic polyneuropathy
- Neuropathic pain in diabetes
This area highlights interest in symptom control for metabolic nerve disease and its impact on daily functioning.
Borderline Personality Disorder
The sponsor also supports clinical research in borderline personality disorder, extending its portfolio beyond pain medicine into psychiatric care.
- Borderline personality disorder
- Psychiatric symptom assessment
This area of interest centers on the clinical burden of mood instability, interpersonal difficulties, and related symptom domains.
